BE1002182A5 - Compositions pharmaceutiques. - Google Patents
Compositions pharmaceutiques. Download PDFInfo
- Publication number
- BE1002182A5 BE1002182A5 BE8800301A BE8800301A BE1002182A5 BE 1002182 A5 BE1002182 A5 BE 1002182A5 BE 8800301 A BE8800301 A BE 8800301A BE 8800301 A BE8800301 A BE 8800301A BE 1002182 A5 BE1002182 A5 BE 1002182A5
- Authority
- BE
- Belgium
- Prior art keywords
- pharmaceutically acceptable
- pharmaceutical compositions
- relates
- pyrano
- dioxo
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
L'invention concerne la pharmacie. Elle a pour objet une composition pharmaceutique dont le constituant actif est l'acide 9-éthyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano-(3,2-g)-quinoléine-2,8-dicarboxylique ou un dérivé pharmaceutiquement acceptable de celui-ci qui est mélangé avec adjuvant ou excipient pharmaceutiquement acceptable, la composition étant propre à l'administration topique sur la peau d'un patient, mais impropre à l'administration par voie orale ou dans l'oeil.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878706242A GB8706242D0 (en) | 1987-03-17 | 1987-03-17 | Formulation |
GB888800833A GB8800833D0 (en) | 1988-01-14 | 1988-01-14 | Formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
BE1002182A5 true BE1002182A5 (fr) | 1990-10-02 |
Family
ID=26292020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE8800301A BE1002182A5 (fr) | 1987-03-17 | 1988-03-16 | Compositions pharmaceutiques. |
Country Status (10)
Country | Link |
---|---|
US (1) | US4868192A (fr) |
EP (1) | EP0294914A3 (fr) |
BE (1) | BE1002182A5 (fr) |
CH (1) | CH675356A5 (fr) |
DK (1) | DK143188A (fr) |
FR (1) | FR2612397A1 (fr) |
GB (1) | GB2202145B (fr) |
GR (1) | GR880100159A (fr) |
LU (1) | LU87161A1 (fr) |
PT (1) | PT86998B (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE38628E1 (en) * | 1986-12-23 | 2004-10-19 | Fisons Plc | Pharmaceutical compositions |
DE3787274T2 (de) * | 1986-12-23 | 1994-01-27 | Fisons Plc | Pharmazeutische Präparate, die eine wässerige Lösung eines Pyranoquinolins enthalten. |
US5198221A (en) * | 1989-05-17 | 1993-03-30 | Fisons Plc | Pharmaceutical composition |
GB8911259D0 (en) * | 1989-05-17 | 1989-07-05 | Fisons Plc | Inhalation medicament |
US5686095A (en) * | 1995-10-23 | 1997-11-11 | Price, Jr.; Francis W. | Method of treating canker sores |
GB9810949D0 (en) | 1998-05-22 | 1998-07-22 | Hewlett Healthcare Limited | Formulation |
US8263580B2 (en) * | 1998-09-11 | 2012-09-11 | Stiefel Research Australia Pty Ltd | Vitamin formulation |
US6861442B1 (en) * | 1998-12-30 | 2005-03-01 | Sugen, Inc. | PYK2 and inflammation |
PL2526930T3 (pl) * | 2005-06-01 | 2014-05-30 | Glaxosmithkline Ip Dev Ltd | Formulacja witaminowa |
GB2587402B (en) | 2019-09-27 | 2023-05-10 | Hewlett Healthcare Ltd | Formulation |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2022078A (en) * | 1977-05-04 | 1979-12-12 | Fisons Ltd | 4,6-Dioxo-4H,6H-pyrano[3,2- g]quinoline-2,8-dicarbocyclic Acids |
GB2187953A (en) * | 1986-03-15 | 1987-09-23 | Fisons Plc | Nedocromil composition |
EP0272057A2 (fr) * | 1986-12-19 | 1988-06-22 | FISONS plc | Compositions pharmaceutiques contenant des pyranoquinoléines |
EP0279121A2 (fr) * | 1986-12-23 | 1988-08-24 | FISONS plc | Compositions pharmaceutiques contenant une solution aqueuse d'une pyranoquinoline |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4474787A (en) * | 1977-05-04 | 1984-10-02 | Fisons Limited | 7,6 Dioxo-4H,6H-pyrano[3,2-g]quinoline dicarboxylic acids and anti-allergic use thereof |
FR2440371A1 (fr) * | 1978-10-31 | 1980-05-30 | Fisons Ltd | Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer |
EP0162556B1 (fr) * | 1984-04-13 | 1991-11-06 | FISONS plc | Formes et formulations des sels de sodium de nédocromil |
-
1988
- 1988-02-29 EP EP19880301721 patent/EP0294914A3/fr not_active Withdrawn
- 1988-02-29 GB GB8804697A patent/GB2202145B/en not_active Expired - Fee Related
- 1988-03-14 US US07/167,343 patent/US4868192A/en not_active Expired - Fee Related
- 1988-03-15 GR GR880100159A patent/GR880100159A/el unknown
- 1988-03-15 CH CH997/88A patent/CH675356A5/fr not_active IP Right Cessation
- 1988-03-16 BE BE8800301A patent/BE1002182A5/fr not_active IP Right Cessation
- 1988-03-16 LU LU87161A patent/LU87161A1/fr unknown
- 1988-03-16 DK DK143188A patent/DK143188A/da not_active Application Discontinuation
- 1988-03-17 PT PT86998A patent/PT86998B/pt not_active IP Right Cessation
- 1988-03-17 FR FR8803450A patent/FR2612397A1/fr not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2022078A (en) * | 1977-05-04 | 1979-12-12 | Fisons Ltd | 4,6-Dioxo-4H,6H-pyrano[3,2- g]quinoline-2,8-dicarbocyclic Acids |
GB2187953A (en) * | 1986-03-15 | 1987-09-23 | Fisons Plc | Nedocromil composition |
EP0272057A2 (fr) * | 1986-12-19 | 1988-06-22 | FISONS plc | Compositions pharmaceutiques contenant des pyranoquinoléines |
EP0279121A2 (fr) * | 1986-12-23 | 1988-08-24 | FISONS plc | Compositions pharmaceutiques contenant une solution aqueuse d'une pyranoquinoline |
Non-Patent Citations (3)
Title |
---|
BIOCHEMICAL PHARMACOLOGY, vol. 36, no. 4, février 1987, pages 562-565, Pergamon Journals Ltd, GB; A.M. LUCAS et al.: "Cromolyn inhibition of protein kinase C activity" * |
J. ALLERGY CLIN. IMMUNOL., vol. 83, no. 1, 1989, page 195, résumé no. 96; H.P. VAN BEYER et al.: "Nedocromil sodium cream (NSC) in the treatment of atopic dermatitis (AD): a double-blind study" * |
JOURNAL OF MEDICINAL CHEMISTRY, vol. 28, no. 12, 1985, pages 1832-1842, American Chemical Society; H. CAIRNS et al.: "New antiallergic pyrano[3,2-gÜquinoline-2,8-dicarboxylic acids with potential for the topical treatment of asthma" * |
Also Published As
Publication number | Publication date |
---|---|
GB2202145A (en) | 1988-09-21 |
PT86998A (pt) | 1988-04-01 |
GB2202145B (en) | 1991-01-02 |
CH675356A5 (fr) | 1990-09-28 |
DK143188A (da) | 1988-09-18 |
US4868192A (en) | 1989-09-19 |
GB8804697D0 (en) | 1988-03-30 |
GR880100159A (el) | 1989-01-31 |
EP0294914A3 (fr) | 1990-10-10 |
PT86998B (pt) | 1992-06-30 |
EP0294914A2 (fr) | 1988-12-14 |
DK143188D0 (da) | 1988-03-16 |
LU87161A1 (fr) | 1988-08-23 |
FR2612397A1 (fr) | 1988-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT8619675A0 (it) | Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale. | |
DE69331409D1 (de) | Oral 1alpha-hydroxyprevitamin d | |
DZ1078A1 (fr) | Formulation pharmaceutiques de substance labiles aux acides pour administration orale. | |
DZ1077A1 (fr) | Nouvelles préparation pharmaceutique pour administration orale. | |
ATE108657T1 (de) | Galanthemin enthaltende pharmazeutische formulierung zur behandlung des alkoholismus. | |
GR3004509T3 (fr) | ||
CA2301017A1 (fr) | Utilisation de gallate de propyle pour augmenter la biodisponibilite de produits pharmaceutiques administres par voie orale | |
BE900605A (fr) | Compositions pharmaceutiques a activite antiinflammatoire et/our analgesique, non ulcerogenes. | |
NO890194L (no) | Galenisk middel. | |
NO863620D0 (no) | Fremgangsmaate for fremstilling av et farmasoeytisk preparat | |
ES2052717T3 (es) | Uso de derivados de indolona para la preparacion de medicamentos para el tratamiento de la enfermedad de parkinson. | |
DK203787A (da) | Praeparat til nasal administrering | |
OA09023A (fr) | Composition pharmaceutique, administrable par voie orale, destinée à réduire les effets des b-lactamines. | |
RU94045950A (ru) | Фармацевтический препарат и способ его приготовления | |
ES2045182T3 (es) | Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen. | |
BE1002182A5 (fr) | Compositions pharmaceutiques. | |
DK515489D0 (da) | Dispergerbar laegemiddelformulering | |
DZ2316A1 (fr) | Micro sphères pharmaceutiques d'acide valproique pour administration orale. | |
BE1000722A4 (fr) | Compositions pharmaceutiques de polypeptides adaptees a la resorption gastro-intestinale. | |
FR2660192B1 (fr) | Formulation liposomiales pour l'administration topique ou vaginale de medicaments. | |
IT8219482A0 (it) | Composizione farmaceutica per la cura di affezioni della cavita'orale. | |
BE1002256A3 (fr) | Medicaments. | |
ATE91890T1 (de) | Herstellung eines arzneimittels gegen arthritis und rheumatismus. | |
HUP9800623A2 (hu) | (+)-O-demetil-tramadol felhasználása fájdalomcsillapító hatású orális gyógyszerkészítmények előállítására | |
FR2602680B1 (fr) | Compositions pharmaceutiques pour l'administration par voie nasale |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: FISONS P.L.C. Effective date: 19920331 |